Weight loss surgery is a highly effective treatment for patients with morbid obesity,
and over the last decade the number of bariatric operations has increased steadily.
Bariatric surgery not only decreases the body mass index but has also a positive effect
on patients’ co-morbidities, such as type 2 diabetes, hypertension, and sleep apnea,
thus extending life expectancy [
[1]
]. Moreover, bariatric surgery has been associated with a significantly lower incidence
of obesity-associated cancer and cancer-related mortality [
[2]
].To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Surgery for Obesity and Related DiseasesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes.N Engl J Med. 2017; 376: 641-651
- Association of bariatric surgery with cancer risk and mortality in adults with obesity.JAMA. 2022; 327: 2423-2433
- Fourth IFSO Global Registry Report 2018.Dendrite Clinical Systems Ltd, Henley-on-Thames, Oxfordshire, United Kingdom2018
- Quality of follow-up: systematic review of the research in bariatric surgery.Ann Surg. 2016; 263: 875-880
- 5-year follow-up at an accredited community bariatric practice: what is an acceptable follow-up rate?.Surg Obes Relat Dis. 2022; 18: 505-510
Article info
Publication history
Published online: February 01, 2023
Publication stage
In Press Journal Pre-ProofIdentification
Copyright
Crown Copyright © 2023 Published by Elsevier Inc. on behalf of American Society for Metabolic and Bariatric Surgery. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Reply to Schlottmann et al.Surgery for Obesity and Related Diseases
- PreviewI thank Schlottmann et al. for their interest in my paper, “5-Year Follow-Up at an Accredited Community Bariatric Practice: What Is an Acceptable Follow-Up Rate?” [1]. Schlottmann et al. use this occasion as a call to action, and correctly term the lack of long-term follow-up the “Achilles heel” of metabolic and bariatric surgery [2]. They correctly point out the dismal worldwide follow-up of bariatric patients [3]. Even in countries with socialized healthcare, follow-up is poor. For example, in Sweden, there are regional differences in follow-up, with some areas reporting only 15% follow-up at 2 years [4].
- Full-Text
- Preview
